The Use of Statins for Myocardial Death Prevention
Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
The administration of high dose HMG-CoA reductase inhibitors (Statins) to patients with acute
ST-elevation MI (hypoxia/ischemia) who are treated with primary PCI (reoxygenation/
reperfusion) will protect their cardiomyocytes from death and thus preserve LV ejection
fraction.